Page last updated: 2024-08-22

n-methylaspartate and 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate

n-methylaspartate has been researched along with 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, J; Greenberg, DA; Lustig, HS; von Brauchitsch, KL1
Gaspary, HL; Graham, SH; Simon, RP1
Meldrum, BS1

Reviews

1 review(s) available for n-methylaspartate and 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate

ArticleYear
The role of glutamate in epilepsy and other CNS disorders.
    Neurology, 1994, Volume: 44, Issue:11 Suppl 8

    Topics: Animals; Central Nervous System Diseases; Epilepsy; Glutamic Acid; Humans; Lamotrigine; Mice; N-Methylaspartate; Parkinson Disease; Piperazines; Pyrimidines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Triazines

1994

Other Studies

2 other study(ies) available for n-methylaspartate and 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate

ArticleYear
A novel inhibitor of glutamate release reduces excitotoxic injury in vitro.
    Neuroscience letters, 1992, Aug-31, Volume: 143, Issue:1-2

    Topics: Animals; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Glutamates; Glutamic Acid; N-Methylaspartate; Neurons; Neurotoxins; Potassium Chloride; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Channels; Tetrodotoxin; Veratridine

1992
BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis.
    European journal of pharmacology, 1994, Sep-12, Volume: 262, Issue:3

    Topics: Analysis of Variance; Animals; Binding, Competitive; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Hippocampus; Injections, Intraperitoneal; Injections, Intravenous; Male; Microdialysis; N-Methylaspartate; Necrosis; Neurons; Observer Variation; Pipecolic Acids; Prosencephalon; Pyrimidines; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Reperfusion Injury

1994